Allergic rhinitis and COVID-19: friends or foes?
Show more: Authors information and Publication history
Authors Information
1Allergy Outpatient Clinic, Turin, Italy
2Allergy and Pneumology Outpatient Clinic, Bergamo, Italy
3Pediatric National Healthcare System, Turin
4Institute for Biomedical Research and Innovation, National Research Council, Palermo, Italy
5Ospedale Santa Chiara, Trento, Italy
6Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy
7Thoracic Disease Research Unit, Mayo Clinic, Rochester (MN), U.S.A.
8Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy
9Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
10Department of Medicine, University of Verona - Verona University Hospital, Verona, Italy
11Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy
12Departmental Unit of Allergology, Immunology and Pulmonary Diseases, Fondazione Poliambulanza, Brescia, Italy
History
Published: 09 September 2021
Accepted: 06 September 2021
Received: 21 April 2021
SUMMARY
Allergic rhinitis (AR) is a common disease affecting up to 40% of the general population worldwide. In the Coronavirus 2019 (COVID-19) pandemic era, many observational studies analysing the effect of asthma and chronic obstructive pulmonary disease on the risk of developing COVID-19 were conducted, while data on AR are limited.In this paper, we review the risk of developing SARS-Cov-2 infection carried by AR patients, the outcomes of those with COVID-19 disease, and the COVID-19 influence on the allergic and nasal symptoms and the psychological status of AR patients, in both adult and paediatric populations.AR patients seem to be protected from COVID 19 infection. Even if data about the influence of AR on the severity of COVID-19 disease are still not conclusive, it seems that being an AR patient does not increase the risk of poor COVID-19 prognoses. The clinical manifestation of AR can be distinguished by COVID-19 symptoms. Treating AR adequately is also strongly recommended, especially during pandemic.
